ARIPIPRAZOLE
| Brand name | ABILIFY MAINTENA KIT |
|---|---|
| Active ingredient | ARIPIPRAZOLE |
| Strength | 300MG |
| Dosage form | FOR SUSPENSION, EXTENDED RELEASE |
| Route | INTRAMUSCULAR |
| Modality | Small molecule |
| FDA approval | September 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12691056 | April 2041 | use U-3245 |
| 11648347 | April 2034 | product |
| 10525057 | March 2034 | use U-543 |
| 11154553 | September 2033 | use U-3245 |
| 10980803 | September 2033 | use U-1632 |
| 11344547 | September 2033 | use U-814 |
| 11400087 | September 2033 | use U-1632 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.